Andrew Miller

About Andrew Miller

Andrew Miller is a director at Alto Neuroscience.

Form D filings name Andrew Miller as a director at ReAlta Life Sciences.

Andrew Miller reports to the SEC as a director or officer of 3 public companies, including Kyverna Therapeutics (KYTX) and Karuna Therapeutics (KRTX).

Andrew Miller first appears on SEC filings in 2019.

Experience

This experience comes from SEC filings. The years are when the filings name Andrew Miller in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Andrew Miller works with at each company, as listed on that company's latest Form D.

Sources

1. SECReAlta Life Sciences, Inc. Form D, filed May 21, 2025
2. SECForms 3, 4 and 5 filed by Andrew Miller (SEC filer 1777760)